CLEVER LEAVES HOLDINGS INC

NASDAQ: CLVRW (Clever Leaves Holdings Inc.)

Last update: 4 days ago, 9:15PM

0.037

0.00 (4.48%)

Previous Close 0.036
Open 0.990
Volume 21,050
Avg. Volume (3M) 10,339
52 Weeks Range
0.010 (-73%) — 0.238 (538%)
Profit Margin -102.77%
Operating Margin (TTM) -105.91%
Quarterly Revenue Growth (YOY) 5.40%
Total Debt/Equity (MRQ) 8.62%
Current Ratio (MRQ) 2.40
Operating Cash Flow (TTM) -11.51 M
Levered Free Cash Flow (TTM) -2.25 M
Return on Assets (TTM) -23.39%
Return on Equity (TTM) -61.27%

AIStockmoo Score

-0.1
Low debt. Weak profitability. Ample short-term liquidity. Negative cash flow. info
From our AI Insight report's view of expected return against risk. info NA
Relative Valuation info NA
Implied Growth info NA
Valuation History info NA
Return on Capital info NA
Earnings Trend info NA
Holdings' Value info NA
Risk Premium info NA
Market Valuation info NA
From our AI technical analysis of the chart. info NA
Trend Strength info NA
Technical Setup info NA
Candle Patterns info NA
Medium-Term Trend info NA
No recent price targets, so based on how targets have been revised. info
Holdings' Sentiment info NA
News Mood info NA
Insider Activity info NA
Institutional Flow info NA
Short Interest info NA
Market environment cautious. info
Sector outperforming the market.
No pillar has a clear reading, so the score is unchanged.
Price Volatility info NA
No clear trend across the short, medium and long term. info
No clear signal from support and resistance. info
Final Score -0.06
Show all

Market Trend

Short Term Medium Term
Industry Drug Manufacturers - Specialty & Generic (US) Mixed Mixed
Drug Manufacturers - Specialty & Generic (Global) Mixed Mixed
Stock Clever Leaves Holdings Inc. - -

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B Score
CLVRW - - - - -0.1
ZYBT 72 M - - 2.13 -1.7
SHPH 17 M - - 0.200 -2.4
CANB 2 M - 0.233 33.49 -1.4
CYTHW - - - - -3.1
BIOA - - - 0.680 -1.9

Select this tab to load the latest available analysis.

Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, standardized extracts, and oral solutions, as well as tetrahydrocannabinol flower. The company was incorporated in 2017 and is based in Tocancipá, Colombia.

Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic

No data within this time range.

No data within this time range.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

Risk / Reward
TP1:
TP2:

Loss to SL against profit to each target, from EP. A ratio of 2 or more is usually sought.

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria